Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of potential drug-drug interaction (pDDI) frequency studies in the intensive care unit (ICU).|
|Full bibliographic reference||Bakker T, Dongelmans DA, Nabovati E, Eslami S, de Keizer NF, Abu-Hanna A, Klopotowska JE. Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations. J Clin Pharmacol. 2021.|
(full-text if available)
|Read the full-text of this reporting guideline.|
|Study design||Observational studies|
|Applies to the whole report or to individual sections of the report?||Procedure/Method, Study characteristics (participants etc.)|
|Record last updated on||March 10, 2022|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.